ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,483, issued on April 29, was assigned to ACCESS TO ADVANCED HEALTH INSTITUTE (Seattle).
"Solanesol vaccine adjuvants and methods of preparing same" was invented by Christopher Bradford Fox (Sumner, Wash.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure describes the use of solanesol as an adjuvant in vaccine compositions, as well as related prophylactic and therapeutic methods. Solanesol may be used to replace squalene in vaccine compositions with similar or superior immunostimulatory effects. Solanesol, which is solid at room temperature, may be formulated for use in vaccine compositions by heating above its melting temperature in an a...